Related Experiment Video
Updated: Jan 25, 2026

Phenotypic Analysis of Rodent Malaria Parasite Asexual and Sexual Blood Stages and Mosquito Stages
Published on: May 30, 2019
Liver stage malaria infection is controlled by host regulators of lipid peroxidation
Heather S Kain1, Elizabeth K K Glennon1,2, Kamalakannan Vijayan1,2
1Center for Infectious Disease Research, Seattle Biomedical Research Institute, Seattle, WA, USA.
Abstract:
The facets of host control during Plasmodium liver infection remain largely unknown. We find that the SLC7a11-GPX4 pathway, which has been associated with the production of reactive oxygen species, lipid peroxidation, and a form of cell death called ferroptosis, plays a critical role in control of Plasmodium liver stage infection. Specifically, blocking GPX4 or SLC7a11 dramatically reduces Plasmodium liver stage parasite infection. In contrast, blocking negative regulators of this pathway, NOX1 and TFR1, leads to an increase in liver stage infection. We have shown previously that increased levels of P53 reduces Plasmodium LS burden in an apoptosis-independent manner. Here, we demonstrate that increased P53 is unable to control parasite burden during NOX1 or TFR1 knockdown, or in the presence of ROS scavenging or when lipid peroxidation is blocked. Additionally, SLC7a11 inhibitors Erastin and Sorafenib reduce infection. Thus, blocking the host SLC7a11-GPX4 pathway serves to selectively elevate lipid peroxides in infected cells, which localize within the parasite and lead to the elimination of liver stage parasites.
Insights
Blocking the SLC7a11-GPX4 pathway in host cells eliminates Plasmodium liver stage parasites by increasing lipid peroxides. This pathway is critical for controlling malaria parasite infection during its liver stage.
Area of Science:
- Immunology
- Parasitology
- Cell Biology
Background:
- Host control mechanisms during Plasmodium liver infection are not well understood.
- The SLC7a11-GPX4 pathway is linked to reactive oxygen species, lipid peroxidation, and ferroptosis.
Purpose of the Study:
- To investigate the role of the SLC7a11-GPX4 pathway in controlling Plasmodium liver stage infection.
- To determine how host factors influence parasite burden in the liver.
Main Methods:
- Inhibition of GPX4 and SLC7a11 in host cells.
- Knockdown of NOX1 and TFR1, negative regulators of the pathway.
- Assessment of Plasmodium liver stage parasite burden.
- Evaluation of P53's role in parasite control under various conditions.
- Treatment with SLC7a11 inhibitors Erastin and Sorafenib.
Main Results:
- Blocking GPX4 or SLC7a11 significantly reduced Plasmodium liver stage infection.
- Inhibition of NOX1 and TFR1 increased liver stage infection.
- Increased P53 levels failed to control parasite burden when the SLC7a11-GPX4 pathway was compromised or ROS scavenging was employed.
- SLC7a11 inhibitors Erastin and Sorafenib reduced Plasmodium infection.
- Elevated lipid peroxides localized within the parasite, leading to parasite elimination.
Conclusions:
- The host SLC7a11-GPX4 pathway is essential for controlling Plasmodium liver stage infection.
- Targeting this pathway selectively increases lipid peroxides in infected cells, eliminating liver stage parasites.
- This pathway represents a potential therapeutic target for malaria treatment.
Related Concept Videos
Stages of Infection
What are Lipids?
Lipid Digestion
Structure of Lipids
Hormonal Regulation
Autoxidation of Ethers to Peroxides and Hydroperoxides

